Browsing by Author Filippatos, T. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 59  next >
TitleAuthor(s)Issue date
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Nakou, E. S.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Alterations in electrolyte equilibrium in patients with acute leukemiaFilippatos, T. D.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015
Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic SyndromeLagos, K. G.; Filippatos, T. D.; Tsimihodimos, V.; Gazi, I. F.; Rizos, C.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Bairaktari, E. T.; Kiortsis, D. N.; Elisaf, M. S.24-Nov-2015
Combination drug treatment in patients with non-alcoholic fatty liver diseaseFilippatos, T. D.; Elisaf, M. S.24-Nov-2015
Combination of fenofibrate with non-statin drug regimensAgouridis, A. P.; Filippatos, T. D.; Derdemezis, C. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolismAgouridis, A. P.; Filippatos, T. D.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary HyperlipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Christogiannis, L. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemiaNakou, E. S.; Filippatos, T. D.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndromeFilippatos, T. D.; Gazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli studyFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Georgoula, M.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaKostapanos, M. S.; Derdemezis, C. S.; Filippatos, T. D.; Milionis, H. J.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritisDerdemezis, C. S.; Filippatos, T. D.; Voulgari, P. V.; Tselepis, A. D.; Drosos, A. A.; Kiortsis, D. N.24-Nov-2015
Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in healthy obese womenTzotzas, T.; Filippatos, T. D.; Triantos, A.; Bruckert, E.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015
Effects of combination of orlistat and micronised fenofibrate on lipid profile in overweight and obese patients with metabolic syndromeFilippatos, T. D.; Kiortsis, D. N.; Tselepis, A. D.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaNakou, E. S.; Filippatos, T. D.; Kiortsis, D. N.; Derdemezis, C. S.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patientsNakou, E. S.; Filippatos, T. D.; Agouridis, A. P.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015
Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot studyDerdemezis, C. S.; Filippatos, T. D.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic SyndromeDerdemezis, C. S.; Filippatos, T. D.; Nakou, E. S.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015